CANDEL THERAPEUTICS, INC. Deferred Tax Assets, Deferred Income
CANDEL THERAPEUTICS, INC. (CADL) had Deferred Tax Assets, Deferred Income of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2024-03-28
- 2023-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2022-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2021-12-31: Deferred Tax Assets, Deferred Income $34.00K.
- 2020-12-31: Deferred Tax Assets, Deferred Income $68.00K.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $34.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $68.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |